Very few medications (i.e., disulfiram, naltrexone and acamprosate) are approved for the treatment of alcoholism and their effects are suboptimal. The development of new effective and safe pharmacological agents to treat alcoholic patients is crucial, together with the need to identify predictors of outcomes in different subsets of patients.
Addolorato, G., Mirijello, A., Leggio, L., Alcohol addiction: toward a patient-oriented pharmacological treatment, <<EXPERT OPINION ON PHARMACOTHERAPY>>, 2013; 14 (16): 2157-2160. [doi:10.1517/14656566.2013.834047] [http://hdl.handle.net/10807/51892]
Alcohol addiction: toward a patient-oriented pharmacological treatment
Addolorato, Giovanni;
2013
Abstract
Very few medications (i.e., disulfiram, naltrexone and acamprosate) are approved for the treatment of alcoholism and their effects are suboptimal. The development of new effective and safe pharmacological agents to treat alcoholic patients is crucial, together with the need to identify predictors of outcomes in different subsets of patients.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
